The COX-2 inhibitor, celecoxib, exhibits antitumorigenic and antimeta-static effects for ovarian cancer in vitro and in vivo

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2013-07, Vol.130 (1), p.e125-e126
Main Authors: Schuler, K, Zhou, C, Zong, Y, Gehrig, P, Bae-Jump, V
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2013.04.360